John Bencich
2015
In 2015, John Bencich earned a total compensation of $411.1K as Executive Vice President and Chief Financial Officer and Chief Operating Officer at OncoGenex Pharmaceuticals, a 31% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $53,820 |
---|---|
Option Awards | $26,491 |
Salary | $307,500 |
Stock Awards | $23,250 |
Total | $411,061 |
Bencich received $307.5K in salary, accounting for 75% of the total pay in 2015.
Bencich also received $53.8K in non-equity incentive plan, $26.5K in option awards and $23.3K in stock awards.
Rankings
In 2015, John Bencich's compensation ranked 11,494th out of 13,638 executives tracked by ExecPay. In other words, Bencich earned more than 15.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,494 | 16th |
Manufacturing | 4,406 | 15th |
Chemicals And Allied Products | 1,626 | 12th |
Drugs | 1,344 | 12th |
In Vitro and In Vivo Diagnostic Substances | 63 | 17th |
Bencich's colleagues
We found two more compensation records of executives who worked with John Bencich at OncoGenex Pharmaceuticals in 2015.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019